Viewing Study NCT04232761


Ignite Creation Date: 2025-12-24 @ 11:59 AM
Ignite Modification Date: 2025-12-24 @ 11:59 AM
Study NCT ID: NCT04232761
Status: COMPLETED
Last Update Posted: 2024-07-17
First Post: 2020-01-15
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Gather Information on the Safety and How Radium-223 Dichloride, an Alpha Particle-emitting Radioactive Agent, Works Under Routine Clinical Practice in Taiwan in Patients With Castration-resistant Prostate Cancer (CRPC) Which Has Spread to the Bone
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module